Table Of Contents

1. Introduction

 1.1 Market Definition & Scope

 1.2 Research Assumptions & Abbreviations

 1.3 Research Methodology

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size by Biomarker

  2.3.2 Market Size by Technology

  2.3.3 Market Size by End User

  2.3.4 Market Size by Application

 2.4 Market Share & Bps Analysis by Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

   3.4.1 Reagents, Consumables, Sample Collection & Sequencing Technology Suppliers

  3.4.2 Diagnostic Manufacturers & Bioinformatics Providers

  3.4.3 Clinical Laboratories, Hospitals, Research Institutes & Distribution Networks

  3.4.4 Oncology Centers, Healthcare Providers, Fertility Clinics & End-Users

 3.5 Industry Life Cycle Assessment

 3.6 Parent Market Overview

 3.7 Market Risk Assessment

4. Statistical Insights & Trends Reporting

4.1 Liquid Biopsy Testing & Diagnostic Technology Metrics

4.1.1 Share (%) of liquid biopsy testing performed using circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), extracellular vesicles, and other biomarker technologies globally.

4.1.2 Growth (%) in liquid biopsy test volumes and advanced molecular diagnostic adoption during 2025 and 2026.

4.1.3 Increase (%) in investments toward next-generation sequencing (NGS) and AI-driven bioinformatics platforms globally.

4.2 Oncology & Precision Medicine Metrics

4.2.1 Share (%) of liquid biopsy demand generated from cancer screening, therapy selection, treatment monitoring, and minimal residual disease (MRD) applications globally.

4.2.2 Growth (%) in precision oncology and companion diagnostic adoption worldwide.

4.2.3 Increase (%) in utilization of ctDNA-based testing for targeted therapy decision-making globally.

4.3 Early Cancer Detection & Screening Metrics

4.3.1 Share (%) of liquid biopsy demand associated with multi-cancer early detection and population screening programs globally.

4.3.2 Growth (%) in non-invasive cancer screening adoption across healthcare systems worldwide.

4.3.3 Increase (%) in clinical research and commercialization of early cancer detection assays globally.

4.4 Reproductive Health & Non-Oncology Application Metrics

4.4.1 Share (%) of liquid biopsy testing utilized in non-invasive prenatal testing, fertility assessment, and other non-oncology applications globally.

4.4.2 Growth (%) in adoption of reproductive health molecular diagnostics worldwide.

4.4.3 Increase (%) in demand for non-invasive genetic testing solutions globally.

4.5 Regional Healthcare & Genomics Infrastructure Metrics

4.5.1 Share (%) of global liquid biopsy demand concentrated across North America, Europe, and Asia Pacific markets.

4.5.2 Growth (%) in genomic medicine, cancer diagnostics, and precision healthcare investments across emerging economies.

4.5.3 Increase (%) in public and private funding supporting advanced molecular diagnostics and personalized medicine globally.

5. Liquid Biopsy Market Analysis & Forecast, By Biomarker, 2022–2035, Value (USD Billion)

5.1 Introduction

5.2 Circulating Tumour DNA

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

5.3 Circulating Tumour Cells

5.4 Exosomes/Extracellular Vesicles

5.5 Others

6. Liquid Biopsy Market Analysis & Forecast, By Technology, 2022–2035, Value (USD Billion)

    6.1 Introduction

    6.2 Digital

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Analog

7. Liquid Biopsy Market Analysis & Forecast, By End User, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Hospitals & Laboratories

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Research Institutes

 7.4 Pharmaceutical & Biotech Companies

 7.5 Others

8. Liquid Biopsy Market Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

    8.1 Introduction

 8.2 Cancer

  8.2.1 Key Trends

  8.2.2 Market Size & Forecast, 2022–2035

 8.3 Reproductive Health

 8.4 Transplantation

 8.5 Others

9. Liquid Biopsy Market Analysis & Forecast, By Region, 2022–2035, Value (USD Billion)

9.1 Introduction

9.2 North America

 9.2.1 Key Trends

 9.2.2 Liquid Biopsy Market Size & Forecast, By Biomarker, 2022–2035

 9.2.3 Liquid Biopsy Market Size & Forecast, By Technology, 2022–2035

 9.2.4 Liquid Biopsy Market Size & Forecast, By End User, 2022–2035

 9.2.5 Liquid Biopsy Market Size & Forecast, By Application, 2022–2035

 9.2.6 Liquid Biopsy Market Size & Forecast, By Country, 2022–2035

  9.2.6.1 USA

  9.2.6.2 Canada

9.3 Europe

 9.3.1 Key Trends

 9.3.2 Liquid Biopsy Market Size & Forecast, By Biomarker, 2022–2035

 9.3.3 Liquid Biopsy Market Size & Forecast, By Technology, 2022–2035

 9.3.4 Liquid Biopsy Market Size & Forecast, By End User, 2022–2035

 9.3.5 Liquid Biopsy Market Size & Forecast, By Application, 2022–2035

 9.3.6 Liquid Biopsy Market Size & Forecast, By Country, 2022–2035

  9.3.6.1 Germany

  9.3.6.2 UK

  9.3.6.3 France

  9.3.6.4 Italy

  9.3.6.5 Spain

  9.3.6.6 Russia

  9.3.6.7 Poland

  9.3.6.8 Rest of Europe

9.4 Asia-Pacific

 9.4.1 Key Trends

 9.4.2 Liquid Biopsy Market Size & Forecast, By Biomarker, 2022–2035

 9.4.3 Liquid Biopsy Market Size & Forecast, By Technology, 2022–2035

 9.4.4 Liquid Biopsy Market Size & Forecast, By End User, 2022–2035

 9.4.5 Liquid Biopsy Market Size & Forecast, By Application, 2022–2035

 9.4.6 Liquid Biopsy Market Size & Forecast, By Country, 2022–2035

  9.4.6.1 China

  9.4.6.2 India

  9.4.6.3 Japan

  9.4.6.4 South Korea

  9.4.6.5 Australia

  9.4.6.6 ASEAN Countries

  9.4.6.7 Rest of Asia-Pacific

9.5 Latin America

 9.5.1 Key Trends

 9.5.2 Liquid Biopsy Market Size & Forecast, By Biomarker, 2022–2035

 9.5.3 Liquid Biopsy Market Size & Forecast, By Technology, 2022–2035

 9.5.4 Liquid Biopsy Market Size & Forecast, By End User, 2022–2035

 9.5.5 Liquid Biopsy Market Size & Forecast, By Application, 2022–2035

 9.5.6 Liquid Biopsy Market Size & Forecast, By Country, 2022–2035

  9.5.6.1 Brazil

  9.5.6.2 Argentina

  9.5.6.3 Mexico

  9.5.6.4 Colombia

  9.5.6.5 Rest of Latin America

9.6 Middle East & Africa

 9.6.1 Key Trends

 9.6.2 Liquid Biopsy Market Size & Forecast, By Biomarker, 2022–2035

 9.6.3 Liquid Biopsy Market Size & Forecast, By Technology, 2022–2035

 9.6.4 Liquid Biopsy Market Size & Forecast, By End User, 2022–2035

 9.6.5 Liquid Biopsy Market Size & Forecast, By Application, 2022–2035

 9.6.6 Liquid Biopsy Market Size & Forecast, By Country, 2022–2035

  9.6.6.1 UAE

  9.6.6.2 Saudi Arabia

  9.6.6.3 Qatar

  9.6.6.4 Egypt

  9.6.6.5 South Africa

  9.6.6.6 Rest of Middle East & Africa

10. Competitive Landscape

 10.1 Key Players' Positioning

 10.2 Competitive Developments

  10.2.1 Key Strategies Adopted (%), By Key Players, 2025

  10.2.2 Year-Wise Strategies & Development, 2022–2025

  10.2.3 Number Of Strategies Adopted By Key Players, 2025

 10.3 Market Share Analysis, 2025

 10.4 Product/Service & Application Band Benchmarking

  10.4.1 Product/Service Specifications & Features By Key Players

  10.4.2 Product/Service Heatmap By Key Players

  10.4.3 Application Heatmap By Key Players

 10.5 Industry Start-Up & Innovation Landscape

10.6 Key Company Profiles

 10.6.1 Guardant Health, Inc.

  10.6.1.1 Company Overview & Snapshot

  10.6.1.2 Product/Service Portfolio

  10.6.1.3 Key Company Financials

  10.6.1.4 SWOT Analysis

10.6.2 F. Hoffmann-La Roche Ltd.

10.6.3 Illumina, Inc.

10.6.4 QIAGEN N.V.

10.6.5 Exact Sciences Corporation

10.6.6 Bio-Rad Laboratories, Inc.

10.6.7 Thermo Fisher Scientific Inc.

10.6.8 Natera, Inc.

10.6.9 NeoGenomics, Inc.

10.6.10 Myriad Genetics, Inc.

10.6.11 PERSONALS, Inc.

10.6.12 Freenome Holdings, Inc.

10.6.13 GRAIL, LLC

10.6.14 Angle plc

10.6.15 Menarini Silicon Biosystems S.p.A.

10.6.16 Biocept, Inc.

10.6.17 Burning Rock Biotech Limited

10.6.18 Adaptive Biotechnologies Corporation

10.6.19 Sysmex Corporation

10.6.20 MDxHealth SA

11. Analyst Recommendations

 11.1 SNS Insider Opportunity Map

 11.2 Industry Low-Hanging Fruit Assessment

 11.3 Market Entry & Growth Strategy

 11.4 Analyst Viewpoint & Suggestions on Market Growth

12. Assumptions

13. Disclaimer

14. Appendix

 14.1 List Of Tables

 14.2 List Of Figures